Show simple item record

dc.contributor.authorChiappini, Stefania
dc.contributor.authorSchifano, Fabrizio
dc.date.accessioned2020-10-17T00:11:08Z
dc.date.available2020-10-17T00:11:08Z
dc.date.issued2020-10-14
dc.identifier.citationChiappini , S & Schifano , F 2020 , ' What about “Pharming”? Issues Regarding the Misuse of Prescription and Over‐the‐Counter Drugs ' , Brain Sciences . https://doi.org/10.3390/brainsci10100736
dc.identifier.issn2076-3425
dc.identifier.otherPURE: 22804664
dc.identifier.otherPURE UUID: b352d519-ae16-4c53-94e7-f41b08aafe09
dc.identifier.urihttp://hdl.handle.net/2299/23282
dc.description.abstractRecently, a range of prescription and over‐the‐counter (OTC) drugs have emerged as being used recreationally, either on their own or in combination with other substances, both licit and illicit, including new psychoactive substances (NPS). Among them, the misuse of prescription drugs involves not only traditionally recorded substances, such as benzodiazepines and opioid pain relievers, but also gabapentinoids (e.g., pregabalin and gabapentin); some antidepressants, e.g., bupropion and venlafaxine; some second‐generation antipsychotics, e.g., quetiapine and olanzapine. Moreover, the use of some OTC for recreational purposes appears on the increase, especially in vulnerable categories such as young people/youths, including the use of high dosages of the antidiarrheal loperamide; first‐generation antihistamines, e.g., promethazine, cyclizine, and diphenhydramine; cough and cold preparations containing dextromethorphan and/or codeine. In this context, the role of the Internet has rapidly increased, playing a significant role both in the diffusion of emerging trends of drug misuse among users and experimenters, and the marketing, sale, and distribution of drugs through online pharmacies. This phenomenon within the context of a rapidly modifying drug scenario is a globally recognized health problem, determining severe adverse consequences, including fatalities, and represents a challenge for clinicians in general, psychiatrists, public health, and drug‐control policies.en
dc.format.extent4
dc.language.isoeng
dc.relation.ispartofBrain Sciences
dc.subjectdrug diversion
dc.subjectdrug misuse
dc.subjectdrug abuse
dc.subjectnon‐medical drug use
dc.subjectpharmacovigilance
dc.subjectprescribing drugs’ misuse
dc.subjectover‐the‐counter drugs’ misuse
dc.subjectnovel psychoactive substances
dc.titleWhat about “Pharming”? Issues Regarding the Misuse of Prescription and Over‐the‐Counter Drugsen
dc.contributor.institutionDepartment of Clinical and Pharmaceutical Sciences
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.contributor.institutionPsychopharmacology, Drug Misuse and Novel Psychoactive Substances Unit
dc.contributor.institutionSchool of Life and Medical Sciences
dc.description.statusPeer reviewed
rioxxterms.versionVoR
rioxxterms.versionofrecordhttps://doi.org/10.3390/brainsci10100736
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record